| Code | CSB-RA004931MB2HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar of foralumab, targeting CD3 epsilon (CD3E)—a core signaling subunit of the T cell receptor (TCR)-CD3 complex expressed on peripheral T cells. CD3E is essential for coupling antigen recognition to intracellular signal transduction that drives T-cell activation and proliferation, and it contains an ITAM motif that helps initiate downstream signaling events and shape T-cell functional responses.
Foralumab is a fully human anti-CD3 monoclonal antibody developed to modulate immune activity by binding the CD3 epsilon chain of the TCR-CD3 complex. This biosimilar enables researchers to investigate TCR/CD3 engagement biology, including activation thresholds, cytokine output, T-cell subset responses (e.g., regulatory vs effector programs), and receptor-associated signaling mechanisms, in controlled experimental systems. It supports immune-mechanism studies where CD3E/TCR pathway modulation is the focus, providing a consistent antibody reagent for probing CD3-dependent immunobiology and assay development.
There are currently no reviews for this product.